| Patricia Puente, | |
|
15320 W Wallin Dr, Plainfield, IL 60544-2504 | |
| (815) 267-3600 | |
| Not Available |
| Full Name | Patricia Puente |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 15320 W Wallin Dr, Plainfield, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073021366 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Puente, 15320 W Wallin Dr, Plainfield, IL 60544-2504 Ph: () - | Patricia Puente, 15320 W Wallin Dr, Plainfield, IL 60544-2504 Ph: (815) 267-3600 |
News Archive
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) and Health Canada have approved the use of the Maria Research Reactor (Maria) in Poland as a site to irradiate highly-enriched uranium targets for Molybdenum 99 (Mo 99) production. Covidien will use the Mo 99 obtained from Maria in the manufacture of its Technetium 99m (Tc 99m) generators. Patients should begin to benefit from Maria-produced Mo 99 in the United States and Canada later this month.
In 1999 and 2003, an H9N2 influenza strain caused illness in three people in Hong Kong. Scientists are concerned about H9N2 and other emerging types of avian influenza viruses because as they spread—most commonly through poultry—they continually mutate, increasing chances that they may infect humans, evade the body's immune response and become more lethal.
A new class of drugs completing clinical trials soon for rheumatoid arthritis should be examined as a treatment for multiple sclerosis, according to the authors of a University of Alabama at Birmingham study published today in the Proceedings of the National Academy of Sciences.
TransTech Pharma, Inc and Forest Laboratories, Inc., today announced that TransTech Pharma and Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. have entered into a license agreement for the development and commercialization of small molecule compounds discovered and developed by TransTech Pharma.
A relatively new, minimally invasive treatment was 100 percent successful in eradicating small malignant kidney tumors in a study of more than 100 patients, report researchers from Wake Forest University Baptist Medical Center.
› Verified 7 days ago
Mrs. Gail Zielinski Weber, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1708 Scarlett Oak Ct, Plainfield, IL 60586 Phone: 815-210-6166 | |
Christine Flores, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14503 Capital Dr, Plainfield, IL 60544 Phone: 815-254-6718 | |
Mrs. Carla Giovannini, M.A., CCC- SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24562 Norwood Dr, Plainfield, IL 60585 Phone: 815-577-4858 | |
Maria Beatriz Arango De Escobar, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15730 S Howard St, Plainfield, IL 60544 Phone: 815-439-4288 | |
Rebecca Smith, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24035 Pear Tree Cir, Plainfield, IL 60585 Phone: 630-697-3809 | |
Lauren Ledvina, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15732 S Howard St, Plainfield, IL 60544 Phone: 815-577-4000 | |
Anne Marie Pasternock, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24402 W Lockport St, Plainfield, IL 60544 Phone: 815-782-4196 |